Logo image of LNTH

LANTHEUS HOLDINGS INC (LNTH) Stock Price, Quote, News and Overview

NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD

92.51  -0.28 (-0.3%)

After market: 92.51 0 (0%)

LNTH Quote, Performance and Key Statistics

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (1/31/2025, 6:28:38 PM)

After market: 92.51 0 (0%)

92.51

-0.28 (-0.3%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High126.89
52 Week Low52.96
Market Cap6.43B
Shares69.53M
Float67.73M
Yearly Dividend0
Dividend YieldN/A
PE13.33
Fwd PE13.19
Earnings (Next)02-20 2025-02-20/amc
IPO06-25 2015-06-25


LNTH short term performance overview.The bars show the price performance of LNTH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

LNTH long term performance overview.The bars show the price performance of LNTH in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200 250

The current stock price of LNTH is 92.51 USD. In the past month the price increased by 3.41%. In the past year, price increased by 71.31%.

LANTHEUS HOLDINGS INC / LNTH Daily stock chart

LNTH Latest News, Press Releases and Analysis

News Image
12 hours ago - Chartmill

NASDAQ:LNTH is showing decent growth, but is still valued reasonably.

LANTHEUS HOLDINGS INC was identified as an affordable growth stock. NASDAQ:LNTH is showing great growth, but also scores well on profitability. At the same time it seems to be priced reasonably.

News Image
2 days ago - Chartmill

NASDAQ:LNTH is probably undervalued for the fundamentals it is displaying.

LANTHEUS HOLDINGS INC has a stellar value proposition. NASDAQ:LNTH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point.

News Image
4 days ago - Chartmill

Why NASDAQ:LNTH Is a Standout High-Growth Stock in a Consolidation Phase.

Based on a technical and fundamental analysis of NASDAQ:LNTH we ask: Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock?

News Image
a day ago - Lantheus Holdings, Inc.

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

BEDFORD, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

LNTH Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ALC ALCON INC 30.16 45.52B
COO COOPER COS INC/THE 26.09 19.27B
ALGN ALIGN TECHNOLOGY INC 23.51 16.36B
SOLV SOLVENTUM CORP 17.8 12.79B
MMSI MERIT MEDICAL SYSTEMS INC 32.4 6.35B
BLCO BAUSCH + LOMB CORP 28.44 6.11B
ICUI ICU MEDICAL INC 28.94 4.02B
XRAY DENTSPLY SIRONA INC 10.68 3.93B
HAE HAEMONETICS CORP/MASS 16.92 3.47B
NEOG NEOGEN CORP 28.65 2.48B
UFPT UFP TECHNOLOGIES INC 39.18 2.11B
RXST RXSIGHT INC N/A 1.36B

About LNTH

Company Profile

LNTH logo image Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 834 full-time employees. The company went IPO on 2015-06-25. The firm classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol.

Company Info

LANTHEUS HOLDINGS INC

331 Treble Cove Rd

North Billerica MASSACHUSETTS 01862 US

CEO: Mary Anne Heino

Employees: 834

Company Website: https://www.lantheus.com/

Investor Relations: https://investor.lantheus.com

Phone: 19786718001

LNTH FAQ

What is the stock price of LNTH?

The current stock price of LNTH is 92.51 USD.


What is the symbol for LANTHEUS HOLDINGS INC stock?

The exchange symbol of LANTHEUS HOLDINGS INC is LNTH and it is listed on the Nasdaq exchange.


On which exchange is LNTH stock listed?

LNTH stock is listed on the Nasdaq exchange.


Is LNTH a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for LNTH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of LNTH.


Does LNTH stock pay dividends?

LNTH does not pay a dividend.


When does LNTH stock report earnings?

LNTH will report earnings on 2025-02-20, after the market close.


What is the Price/Earnings (PE) ratio of LNTH?

The PE ratio for LNTH is 13.33. This is based on the reported non-GAAP earnings per share of 6.94 and the current share price of 92.51 USD.


What is the Short Interest ratio of LNTH stock?

The outstanding short interest for LNTH is 9.14% of its float.


LNTH Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to LNTH. When comparing the yearly performance of all stocks, LNTH is one of the better performing stocks in the market, outperforming 86.32% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

LNTH Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to LNTH. LNTH gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LNTH Financial Highlights

Over the last trailing twelve months LNTH reported a non-GAAP Earnings per Share(EPS) of 6.94. The EPS increased by 18.63% compared to the year before.


Industry RankSector Rank
PM (TTM) 28.57%
ROA 20.86%
ROE 36.25%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%15.65%
Sales Q2Q%18.37%
EPS 1Y (TTM)18.63%
Revenue 1Y (TTM)24.15%

LNTH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 82% to LNTH. The Buy consensus is the average rating of analysts ratings from 19 analysts.

For the next year, analysts expect an EPS growth of 10.02% and a revenue growth 18.4% for LNTH


Ownership
Inst Owners101.09%
Ins Owners1.46%
Short Float %9.14%
Short Ratio5.24
Analysts
Analysts82.11
Price Target137.39 (48.51%)
EPS Next Y10.02%
Revenue Next Year18.4%